Architecture of the Extended Clearance Model

Why Extend a Hepatic Clearance Model?

A drug disappearing from blood in the liver may be taken up into hepatocytes, metabolized there, sent into bile, or returned to blood by basolateral efflux. These processes are connected, but they are not interchangeable: uptake moves drug into the cell, while metabolism and the two efflux routes remove it from the intracellular space by different mechanisms. A useful model must represent both the pathways and the concentration that drives each one.

The extended clearance model makes those connections explicit. It separates sinusoidal entry from intracellular loss and allows a drug to return to blood or leave through bile. This structure is useful when transporter activity, enzyme activity, or both may influence hepatic disposition. It also makes assumptions visible: a fitted “clearance” is only interpretable if its concentration basis and the process it represents are specified.

Definition: In the extended clearance model, hepatic disposition is represented by fluxes between sinusoidal blood, an intracellular hepatocyte pool, and bile. A flux is an amount of drug transferred per unit time. Each pathway is described by its direction and by a rate law driven by a specified concentration, commonly an unbound concentration at the relevant membrane or within the hepatocyte.

Compartments, Directions, and Concentration Bases

For clarity, let \(C_{s,u}\) denote the unbound drug concentration in sinusoidal plasma, available at the blood-facing hepatocyte membrane. Let \(C_{h,u}\) denote unbound concentration in the hepatocyte pool accessible to transporters and metabolic enzymes. The subscript \(u\) means unbound; it does not mean that the concentration is measured in a particular assay. If a measured value is total concentration, an appropriate unbound fraction or binding model is needed before using it as an unbound concentration.

The architecture contains five conceptually distinct pathways:

Sinusoidal uptake transfers drug from blood into hepatocytes. Its driving concentration is on the blood side, usually \(C_{s,u}\).
Passive diffusion can transfer drug in either direction across the sinusoidal membrane. Its net direction depends on the difference between concentrations on the two sides.
Basolateral efflux returns intracellular drug to sinusoidal blood. Its driving concentration is usually \(C_{h,u}\).
Metabolism transforms intracellular parent drug. Its rate is driven by the concentration accessible to the enzyme, commonly represented as \(C_{h,u}\).
Biliary excretion transfers intracellular drug into bile. Its rate is commonly driven by \(C_{h,u}\), with transporter kinetics determining the exact rate law.

A clearance has units of volume per time. Multiplying a clearance by the concentration that drives the corresponding pathway gives an amount per time. The concentration and clearance must be defined on compatible bases: for example, a clearance referenced to unbound plasma concentration should not be multiplied by total plasma concentration unless the clearance has been converted accordingly.

Model convention: Take flux toward the hepatocyte as positive for sinusoidal uptake and passive diffusion. Take basolateral efflux, metabolism, and biliary excretion as positive when they remove parent drug from the hepatocyte. A reported flux is nonnegative in its stated direction; a net bidirectional flux can be positive or negative.

Writing the Pathway Rate Laws

For linear pathways, write each flux as a clearance multiplied by its driving concentration. Denote the clearances for uptake, passive diffusion, basolateral efflux, metabolism, and biliary excretion by \(CL_{\mathrm{uptake}}\), \(CL_{\mathrm{pass}}\), \(CL_{\mathrm{efflux}}\), \(CL_{\mathrm{met}}\), and \(CL_{\mathrm{bile}}\), respectively. In this simplified linear representation, the pathway rates are:

J_{\mathrm{uptake}}=CL_{\mathrm{uptake}}C_{s,u}, \qquad J_{\mathrm{pass}}=CL_{\mathrm{pass}}(C_{s,u}-C_{h,u})

J_{\mathrm{efflux}}=CL_{\mathrm{efflux}}C_{h,u}, \qquad J_{\mathrm{met}}=CL_{\mathrm{met}}C_{h,u}, \qquad J_{\mathrm{bile}}=CL_{\mathrm{bile}}C_{h,u}

The passive term is a net flux. If \(C_{s,u}>C_{h,u}\), it is inward under the stated sign convention; if \(C_{s,u}<C_{h,u}\), it is outward. By contrast, the uptake expression describes inward transporter-mediated flux and the basolateral expression describes outward transporter-mediated flux. The equations do not assert that these clearances are constant in every setting. Transport can saturate, and metabolism can be nonlinear or time-dependent.

For a saturable transporter, a common rate law is a Michaelis–Menten expression. For example, sinusoidal uptake may be written \(J_{\mathrm{uptake}}=V_{\max,\mathrm{uptake}}C_{s,u}/(K_{m,\mathrm{uptake}}+C_{s,u})\). Here \(V_{\max,\mathrm{uptake}}\) is a maximum flux and \(K_{m,\mathrm{uptake}}\) is the concentration at which the flux is half its maximum, on the concentration basis used to define that parameter. The flux is no longer a fixed clearance times concentration, although a concentration-specific ratio \(J_{\mathrm{uptake}}/C_{s,u}\) can still be calculated.

Worked Example: Calculating the Component Fluxes

Consider hypothetical linear pathway parameters with \(C_{s,u}=0.80\ \mathrm{\mu mol/L}\) and \(C_{h,u}=2.0\ \mathrm{\mu mol/L}\). Let \(CL_{\mathrm{uptake}}=12\ \mathrm{L/h}\), \(CL_{\mathrm{pass}}=3.0\ \mathrm{L/h}\), \(CL_{\mathrm{efflux}}=5.0\ \mathrm{L/h}\), \(CL_{\mathrm{met}}=4.0\ \mathrm{L/h}\), and \(CL_{\mathrm{bile}}=1.5\ \mathrm{L/h}\). Calculate the flux for each pathway.

Uptake: \(J_{\mathrm{uptake}}=12\ \mathrm{L/h}\times0.80\ \mathrm{\mu mol/L}=9.6\ \mathrm{\mu mol/h}\), directed into the hepatocyte.

Passive diffusion: \(J_{\mathrm{pass}}=3.0\ \mathrm{L/h}\times(0.80-2.0)\ \mathrm{\mu mol/L}=-3.6\ \mathrm{\mu mol/h}\). The negative sign means the net passive flux is outward, from the hepatocyte toward sinusoidal blood.

Basolateral efflux: \(J_{\mathrm{efflux}}=5.0\ \mathrm{L/h}\times2.0\ \mathrm{\mu mol/L}=10\ \mathrm{\mu mol/h}\), directed out of the cell.

Metabolism: \(J_{\mathrm{met}}=4.0\ \mathrm{L/h}\times2.0\ \mathrm{\mu mol/L}=8.0\ \mathrm{\mu mol/h}\). Biliary excretion: \(J_{\mathrm{bile}}=1.5\ \mathrm{L/h}\times2.0\ \mathrm{\mu mol/L}=3.0\ \mathrm{\mu mol/h}\). Both remove parent drug from the hepatocyte, but only the latter transfers it into bile.

Each product has units \(\mathrm{\mu mol/h}\), because \((\mathrm{L/h})(\mathrm{\mu mol/L})=\mathrm{\mu mol/h}\). These component calculations do not, by themselves, determine an observed liver clearance: that would require a specified liver model and a consistent account of the drug entering, leaving, and accumulating in the relevant compartments.

Why the Concentration Basis Changes the Answer

A frequent source of error is to multiply a clearance by whichever concentration is easiest to find. That can create a numerically plausible flux with the wrong meaning. For example, if a transporter clearance is defined relative to unbound concentration, using total plasma concentration without converting it will overstate the predicted flux when appreciable drug is bound. The same issue applies inside the hepatocyte: a total intracellular concentration is not automatically the enzyme- or transporter-accessible concentration.

The basis should be traced pathway by pathway. Plasma measurements may be total or unbound; blood and plasma concentrations can differ when drug partitions into blood cells. Intracellular measurements may also be total or unbound. Binding assumptions or conversion factors must therefore be stated, and the basis used to estimate a clearance or kinetic parameter must match the concentration multiplied by that parameter.

Worked Example: Converting Total Concentrations Before Calculating Flux

Suppose a hypothetical drug has total plasma concentration \(C_{p,\mathrm{total}}=10\ \mathrm{\mu mol/L}\) and unbound fraction \(f_{u,p}=0.050\). An uptake clearance of \(8.0\ \mathrm{L/h}\) is defined relative to unbound sinusoidal plasma concentration. Assume, for this calculation, that the unbound sinusoidal concentration equals the calculated unbound plasma concentration.

First calculate the appropriate concentration: \(C_{s,u}=f_{u,p}C_{p,\mathrm{total}}=0.050\times10=0.50\ \mathrm{\mu mol/L}\). Then \(J_{\mathrm{uptake}}=8.0\ \mathrm{L/h}\times0.50\ \mathrm{\mu mol/L}=4.0\ \mathrm{\mu mol/h}\).

Multiplying \(8.0\ \mathrm{L/h}\) by the total concentration of \(10\ \mathrm{\mu mol/L}\) would give \(80\ \mathrm{\mu mol/h}\), twenty times the flux calculated on the specified unbound basis. That result would be inappropriate unless the clearance had instead been defined relative to total plasma concentration.

Suppose separately that \(C_{h,\mathrm{total}}=20\ \mathrm{\mu mol/L}\), with intracellular unbound fraction \(f_{u,h}=0.10\), and that \(CL_{\mathrm{efflux}}=3.0\ \mathrm{L/h}\) is defined relative to unbound intracellular concentration. Then \(C_{h,u}=0.10\times20=2.0\ \mathrm{\mu mol/L}\), and \(J_{\mathrm{efflux}}=3.0\times2.0=6.0\ \mathrm{\mu mol/h}\). This calculation uses a different compartment and a different binding conversion from the uptake calculation.

A Short Justification: Flux Direction and Units

The linear expressions follow from the definition of clearance as a proportionality between flux and its driving concentration. For a one-way pathway with constant clearance \(CL\), \(J=CL\,C\). Its units are consistent:

\frac{\mathrm{volume}}{\mathrm{time}} \times \frac{\mathrm{amount}}{\mathrm{volume}} = \frac{\mathrm{amount}}{\mathrm{time}}

For passive diffusion, the flux must change sign when the concentration gradient reverses and must be zero when the two concentrations are equal. A linear law satisfying both properties is \(J_{\mathrm{pass}}=CL_{\mathrm{pass}}(C_{s,u}-C_{h,u})\), with a nonnegative permeability clearance. Thus a negative value is not a negative physical rate; it records net movement opposite the chosen positive direction. This formulation assumes compatible concentration units and a simplified proportional relationship across the membrane. More detailed membrane models may require additional partition or scaling terms.

The same unit check applies to a saturable transporter: \(V_{\max}C/(K_m+C)\) has flux units because the concentration ratio is dimensionless. This check is useful when combining parameters from different experiments. If concentrations are expressed in different units, or if one kinetic parameter is based on total concentration and another on unbound concentration, conversion is needed before the rates can be compared.

Worked Example: Recognizing Saturation in Uptake

For a hypothetical uptake transporter, let \(V_{\max,\mathrm{uptake}}=24\ \mathrm{\mu mol/h}\) and \(K_{m,\mathrm{uptake}}=2.0\ \mathrm{\mu mol/L}\), both defined on the unbound sinusoidal concentration basis. Calculate the uptake flux at \(C_{s,u}=1.5\ \mathrm{\mu mol/L}\), and compare the apparent clearance with that at \(C_{s,u}=6.0\ \mathrm{\mu mol/L}\).

At \(1.5\ \mathrm{\mu mol/L}\), \(J_{\mathrm{uptake}}=24\times1.5/(2.0+1.5)=36/3.5=10.29\ \mathrm{\mu mol/h}\). The concentration-specific apparent clearance is \(J_{\mathrm{uptake}}/C_{s,u}=10.29/1.5=6.86\ \mathrm{L/h}\).

At \(6.0\ \mathrm{\mu mol/L}\), \(J_{\mathrm{uptake}}=24\times6.0/(2.0+6.0)=144/8.0=18.0\ \mathrm{\mu mol/h}\). The corresponding apparent clearance is \(18.0/6.0=3.00\ \mathrm{L/h}\). Concentration has increased fourfold, but flux has increased only \(18.0/10.29=1.75\)-fold. The declining apparent clearance reflects saturation; it does not mean that the transporter has become a different pathway.

Assumptions, Diagnostics, and Alternatives

An explicit extended clearance model is most interpretable when its assumptions match the biological and experimental setting. A basic compartmental version generally assumes that the modeled hepatocyte pool is sufficiently well mixed to be represented by one concentration, that each pathway has a specified direction and rate law, and that binding conversions are defined. A linear clearance assumes proportionality over the concentration range being modeled; a Michaelis–Menten term instead assumes a saturable rate with a defined concentration basis. If pathway activity changes over time, for example through inhibition or induction, a time-constant clearance may not be adequate.

Several checks help identify a poorly specified model:

Check the units. A clearance multiplied by concentration should produce amount per time; a maximum transporter rate should already have flux units.
Check the direction. Uptake and basolateral efflux are not the same flux with interchangeable labels. A negative net passive flux should be interpreted as movement against the chosen positive direction.
Check the concentration basis. Confirm whether each parameter was defined relative to unbound or total concentration, and whether the concentration belongs to plasma, whole blood, or the hepatocyte.
Check plausible pathway behavior. A saturable uptake flux should approach its maximum rate as its driving concentration becomes large, rather than increasing without bound.
Check what the data can distinguish. If observations only report total hepatic disappearance, they may not separately identify uptake, metabolism, biliary excretion, and return to blood. A detailed pathway structure does not guarantee that every pathway parameter can be estimated independently.

An alternative is to use a single lumped hepatic clearance, which is simpler when only overall disposition is needed and the data do not resolve individual pathways. That approach cannot, however, directly attribute a change to uptake, intracellular metabolism, biliary transport, or basolateral return. The extended model is preferable when those mechanisms matter and there are informative data or defensible prior constraints. Its limitations include greater parameter requirements, sensitivity to concentration-basis errors, and the possibility that a single homogeneous intracellular pool cannot represent spatial or subcellular heterogeneity.

Common pitfall: “The plasma concentration is \(10\ \mathrm{\mu mol/L}\), so multiplying it by the uptake clearance gives the uptake flux.” This is wrong if that clearance is defined relative to unbound concentration and \(10\ \mathrm{\mu mol/L}\) is a total concentration. First convert to the matching concentration basis, then apply the pathway rate law. Also keep pathway identity: a flux returned to blood is not equivalent to metabolism or biliary excretion.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

A linear efflux clearance is defined relative to \(C_{h,u}\). Which concentration should multiply it: total plasma concentration or unbound hepatocyte concentration?
If \(C_{s,u}=3.0\ \mathrm{\mu mol/L}\), \(C_{h,u}=1.0\ \mathrm{\mu mol/L}\), and \(CL_{\mathrm{pass}}=2.0\ \mathrm{L/h}\), what is the net passive flux and its direction?
Why can a saturable uptake transporter have a lower apparent clearance at a higher concentration even while its flux increases?
Name two distinct processes that remove parent drug from the hepatocyte, and state where each sends or transforms the drug.

Solutions. (1) Use unbound hepatocyte concentration, because that is the stated basis of the efflux clearance. (2) \(J_{\mathrm{pass}}=2.0(3.0-1.0)=4.0\ \mathrm{\mu mol/h}\), positive and therefore inward under the convention used here. (3) Flux approaches \(V_{\max}\), so the ratio of flux to concentration can decline as concentration rises. (4) Metabolism transforms parent drug; biliary excretion transfers it into bile. Basolateral efflux is another distinct route, returning parent drug to sinusoidal blood.